EPSTEIN-BARR VIRUS INFECTION
Clinical trials for EPSTEIN-BARR VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new EPSTEIN-BARR VIRUS INFECTION trials appear
Sign up with your email to follow new studies for EPSTEIN-BARR VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New EBV vaccine trial aims to prevent mono and related cancers
⭐️ VACCINE ⭐️ Recruiting nowThis study tests the safety of two experimental vaccines designed to prevent Epstein-Barr virus (EBV) infection, which causes mono and is linked to certain cancers and autoimmune diseases. Healthy adults aged 18 to 29, whether or not they have had EBV before, will receive three d…
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 18, 2026 12:01 UTC
-
Engineered immune cells take on Post-Transplant virus
Disease control Recruiting nowThis study tests a new treatment for Epstein-Barr virus (EBV) infection that can occur after a stem cell transplant. The treatment uses specially engineered immune cells (EBV-TCR-T cells) to find and attack the virus. About 18 adults who have had a stem cell transplant and still …
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Daihong Liu • Aim: Disease control
Last updated May 22, 2026 13:53 UTC